Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Familial Amyloid Polyneuropathy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Familial Amyloid Polyneuropathymarket, defines the market attractiveness level of Familial Amyloid Polyneuropathy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Familial Amyloid Polyneuropathy industry, describes the types of Familial Amyloid Polyneuropathy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Familial Amyloid Polyneuropathy market and the development prospects and opportunities of Familial Amyloid Polyneuropathy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Familial Amyloid Polyneuropathy market in Chapter 13.
By Player:
Alnylam
Pfizer
Proclara Bioscience
GSK
Corino Therapeutics
Arcturus Therapeutics
Ionis
By Type:
FAP-I
FAP-II
FAP-III
FAP-IV
By End-User:
Hospitals and Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Familial Amyloid Polyneuropathy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Familial Amyloid Polyneuropathy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Familial Amyloid Polyneuropathy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Familial Amyloid Polyneuropathy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Familial Amyloid Polyneuropathy Market Analysis and Outlook to 2022
-
7.1 Global Familial Amyloid Polyneuropathy Consumption (2017-2022)
-
7.2 United States Familial Amyloid Polyneuropathy Consumption (2017-2022)
-
7.3 Europe Familial Amyloid Polyneuropathy Consumption (2017-2022)
-
7.4 China Familial Amyloid Polyneuropathy Consumption (2017-2022)
-
7.5 Japan Familial Amyloid Polyneuropathy Consumption (2017-2022)
-
7.6 India Familial Amyloid Polyneuropathy Consumption (2017-2022)
-
7.7 South Korea Familial Amyloid Polyneuropathy Consumption (2017-2022)
8 Region and Country-wise Familial Amyloid Polyneuropathy Market Analysis and Outlook to 2028
-
8.1 Global Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
-
8.2 United States Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
-
8.3 Europe Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
-
8.4 China Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
-
8.5 Japan Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
-
8.6 India Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
-
8.7 South Korea Familial Amyloid Polyneuropathy Consumption Forecast (2022-2028)
9 Global Familial Amyloid Polyneuropathy Market Outlook by Types and Applications to 2022
-
9.1 Global Familial Amyloid Polyneuropathy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global FAP-I Consumption and Growth Rate (2017-2022)
-
9.1.2 Global FAP-II Consumption and Growth Rate (2017-2022)
-
9.1.3 Global FAP-III Consumption and Growth Rate (2017-2022)
-
9.1.4 Global FAP-IV Consumption and Growth Rate (2017-2022)
-
9.2 Global Familial Amyloid Polyneuropathy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Others Consumption and Growth Rate (2017-2022)
10 Global Familial Amyloid Polyneuropathy Market Outlook by Types and Applications to 2028
-
10.1 Global Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global FAP-I Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global FAP-II Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global FAP-III Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global FAP-IV Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Familial Amyloid Polyneuropathy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Familial Amyloid Polyneuropathy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Familial Amyloid Polyneuropathy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Familial Amyloid Polyneuropathy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Familial Amyloid Polyneuropathy Market Competitive Analysis
-
14.1 Alnylam
-
14.1.1 Alnylam Company Details
-
14.1.2 Alnylam Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alnylam Familial Amyloid Polyneuropathy Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Familial Amyloid Polyneuropathy Product and Service
-
14.3 Proclara Bioscience
-
14.3.1 Proclara Bioscience Company Details
-
14.3.2 Proclara Bioscience Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Proclara Bioscience Familial Amyloid Polyneuropathy Product and Service
-
14.4 GSK
-
14.4.1 GSK Company Details
-
14.4.2 GSK Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GSK Familial Amyloid Polyneuropathy Product and Service
-
14.5 Corino Therapeutics
-
14.5.1 Corino Therapeutics Company Details
-
14.5.2 Corino Therapeutics Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Corino Therapeutics Familial Amyloid Polyneuropathy Product and Service
-
14.6 Arcturus Therapeutics
-
14.6.1 Arcturus Therapeutics Company Details
-
14.6.2 Arcturus Therapeutics Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Arcturus Therapeutics Familial Amyloid Polyneuropathy Product and Service
-
14.7 Ionis
-
14.7.1 Ionis Company Details
-
14.7.2 Ionis Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ionis Familial Amyloid Polyneuropathy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Familial Amyloid Polyneuropathy
-
Figure Familial Amyloid Polyneuropathy Picture
-
Table Global Familial Amyloid Polyneuropathy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Familial Amyloid Polyneuropathy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Familial Amyloid Polyneuropathy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Familial Amyloid Polyneuropathy Consumption by Country (2017-2022)
-
Figure United States Familial Amyloid Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Table Europe Familial Amyloid Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Figure China Familial Amyloid Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Figure Japan Familial Amyloid Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Figure India Familial Amyloid Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Familial Amyloid Polyneuropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Familial Amyloid Polyneuropathy Consumption Forecast by Country (2022-2028)
-
Figure United States Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Familial Amyloid Polyneuropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FAP-I Consumption and Growth Rate (2017-2022)
-
Figure Global FAP-II Consumption and Growth Rate (2017-2022)
-
Figure Global FAP-III Consumption and Growth Rate (2017-2022)
-
Figure Global FAP-IV Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global FAP-I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FAP-II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FAP-III Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FAP-IV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Familial Amyloid Polyneuropathy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Familial Amyloid Polyneuropathy Export by Region (Top 5 Countries) (2017-2028)
-
Table Alnylam (Foundation Year, Company Profile and etc.)
-
Table Alnylam Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Familial Amyloid Polyneuropathy Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Familial Amyloid Polyneuropathy Product and Service
-
Table Proclara Bioscience (Foundation Year, Company Profile and etc.)
-
Table Proclara Bioscience Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Proclara Bioscience Familial Amyloid Polyneuropathy Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Familial Amyloid Polyneuropathy Product and Service
-
Table Corino Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Corino Therapeutics Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corino Therapeutics Familial Amyloid Polyneuropathy Product and Service
-
Table Arcturus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Arcturus Therapeutics Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arcturus Therapeutics Familial Amyloid Polyneuropathy Product and Service
-
Table Ionis (Foundation Year, Company Profile and etc.)
-
Table Ionis Familial Amyloid Polyneuropathy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ionis Familial Amyloid Polyneuropathy Product and Service
-
